Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...

Researchers sought to determine whether a reduced dose of apixaban would be as effective as using full-dose apixaban in preventing recurrent VTE in patients with active cancer.

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action. It has a ...

The CATALYST meta-analysis pooled the four studies and identified 5,441 people with acute ischemic stroke and Afib for ...

The primary outcome rates with apixaban 2.5 mg twice daily and 5 mg once daily were 9.0% and 11.3%, respectively, compared with 15.6% in the enoxaparin group and 26.6% in the warfarin group (p = 0 ...

The session focused on the evolution of stroke care, particularly ischemic strokes, which make up 87% of all strokes. It ...

During medical emergencies, when decisions must be made quickly, knowing how blood thinners are affecting a person’s ability ...

Eliquis (apixaban) is a brand-name oral tablet that’s prescribed for preventing or treating certain blood clots in adults. The cost of the drug with and without insurance can depend on several ...

Non-valvular atrial fibrillation accounts for 13–26% of acute ischaemic strokes.1 Direct oral anticoagulants (DOACs) are ...

People with type 2 diabetes who used semaglutide (Ozempic) versus other drugs had a lower risk of Alzheimer's disease and ...

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback. At ...

Eliquis (apixaban) is an anticoagulant used to lower the chance of stroke in people with atrial fibrillation (AFib), a common type of irregular heartbeat (arrhythmia). Most Medicare prescription ...